SCHEMBL17293178

SCHEMBL17293178

CCCCOC(=O)CC(=O)C(C)N(C)C(=O)OC(C)(C)C

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 2/20 0.36
CTSK P43235 2/20 0.36
NAAA Q02083 1/20 0.35
ALDH1A1 P00352 2/20 0.34
DNM1 Q05193 1/20 0.33
NPC1 O15118 3/20 0.33
RAB9A P51151 3/20 0.33
SMN1; SMN2 Q16637 3/20 0.33
ATM Q13315 1/20 0.33
HPGD P15428 2/20 0.32
KDM4E B2RXH2 1/20 0.32
MAPT P10636 1/20 0.32
MAPK1 P28482 1/20 0.32
MCL1 Q07820 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
DGKA P23743 1/20 0.32
CA12 O43570 1/20 0.32
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32
CA14 Q9ULX7 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14924779 0.86 GAA (0.41) CTSKALDH1A1CA12CA1CA2
SCHEMBL18787667 0.82 CYP2D6 (0.36) CTSKCA12CA1CA2CA14
SCHEMBL18787668 0.82 CYP2D6 (0.36) CTSKCA12CA1CA2CA14
SCHEMBL25499813 0.82 AAK1 (0.34) SMN1; SMN2MAPK1
SCHEMBL31485762 0.81 CA2 (0.36) CA12CA1CA2CA14
SCHEMBL7547874 0.78 NAAA (0.37) FAAHCTSKNAAAALDH1A1DNM1
SCHEMBL21294450 0.76 AAK1 (0.35) CTSKCA1CA2CA14
SCHEMBL21294449 0.76 AAK1 (0.35) CTSKCA1CA2CA14
SCHEMBL14924171 0.76 HDAC6 (0.35) CTSKCA12CA1CA2CA14
SCHEMBL16202113 0.76 ALDH1A1 (0.37) CTSKNAAAALDH1A1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3149001-A1 NOVEL PYRAZOLO PYRIMIDINE DERIVATIVES AND THEIR USE AS MALT1 INHIBITORS Novartis AG (CH) 2017-04-05 EP disclosed
WO-2015181747-A1 NOVEL PYRAZOLO PYRIMIDINE DERIVATIVES AND THEIR USE AS MALT1 INHIBITORS NOVARTIS AG (CH) 2015-12-03 WO disclosed